AstraZeneca

News

AstraZeneca improves diabetes pen to maintain its market sha...

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug with the added benefit of glucose reduct

News

AZ COPD drug fails to match GSK rival after disappointing la...

AstraZeneca has said it is analysing “inconsistent” results after a late-stage trial of its Bevespi Aerosphere inhaler in chronic obstructive pulmonary disease (COPD) failed to match the pe

News

AstraZeneca changes contractors as HQ delayed again

AstraZeneca has switched building contractors in a bid to hasten progress on its delayed and over-budget new headquarters, which is under construction in Cambridge.

News

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment of patients with positive non-small cell lung cance

News

AstraZeneca to present the latest cardiovascular research

AstraZeneca and MedImmune will present new data from its Cardiovascular, Renal and Metabolism (CVRM) portfolio for the treatment of patients with overlapping diseases and multiple risk fact

News